PHARMACY

FDA approves expanded Rituxan indication
With this approval — which saw the drug given Priority Review, Breakthrough Therapy Designation and Orphan Drug Designation by the FDA — Rituxan becomes the first biologic therapy for the disease.
Abbott launches new generation of Afinion test system
The Afinion 2 streamlines and simplifies the delivery of accurate measurements of hemoglobin A1c, or HbA1c, and albumin to creatinine ratio results at the point of care, the company said.

Express Scripts, MedAvail pilot Rx kiosks

The companies are rolling out MedAvail’s MedCenter self-service pharmacy kiosks in Phoenix and Tucson, offering securely dispensed chronic and acute prescriptions, as well as OTC medications 24/7.
Amerigen launches generic Targretin capsules

The drug is indicated to treat skin problems that arise from cutaneous T-cell lymphoma in patients who have not responded well to other treatments.
Fred’s closes specialty pharmacy sale

The Memphis-based company unloaded the business unit, EntrustRx, to a CVS Health subsidiary for a $40 million aggregate consideration, plus the value of its inventory.
Lupin intros generic Methergine tablets

The product’s market size was $71.5 million for the 12 months ended April 2018, according to IQVIA data.
Amgen’s Herceptin biosimilar rejected by FDA

The Food and Drug Administration sent Amgen a complete response letter for its Biologics License application for potential Herceptin biosimilar ABP 90.
Lupin gets FDA OK for generic Mycolog-II cream

The generic Mycolog-II cream market size was roughly $62.2 million for the 12 months ended April 2018.
FDA approves Fulphila, the first U.S. Neulasta biosimilar

Fulphila is the first U.S. biosimilar of the drug from Amgen and is indicated to reduce the duration of febrile neutropenia in patients treated with chemotherapy in certain types of cancer.
Thrifty White chooses PrescribeWellness to drive outcomes

The Plymouth, Minn.-based chain will use PrescribeWellness’ platform to offer clinical services, enhance patients’ experiences and offer comprehensive patient engagement and support services — all with the goal of improved outcomes, the companies said.